Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial-Reference-Cited by-同舟云学术

Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial

Published:2014-04 Issue:4 Volume:15 Page:464-473
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Dearnaley David P,Jovic Gordana,Syndikus Isabel,Khoo Vincent,Cowan Richard A,Graham John D,Aird Edwin G,Bottomley David,Huddart Robert A,Jose Chakiath C,Matthews John H L,Millar Jeremy L,Murphy Claire,Russell J Martin,Scrase Christopher D,Parmar Mahesh K B,Sydes Matthew R

Publisher

Elsevier BV

Subject

Oncology

Reference40 articles.

1. NCCN clinical practice guidelines in oncology: prostate cancer;Mohler;J Natl Compr Canc Netw,2010

2. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial;Dearnaley;Lancet,1999

3. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial;Dearnaley;Lancet Oncol,2012

4. Randomised pilot study of dose escalation using conformal radiotherapy in prostate cancer: long-term follow-up;Creak;Br J Cancer,2013

5. Long-term results of the M D Anderson randomized dose-escalation trial for prostate cancer;Kuban;Int J Radiat Oncol Biol Phys,2008

Cited by 403 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous Focal Boost With Stereotactic Radiation Therapy for Localized Intermediate- to High-Risk Prostate Cancer: Primary Outcomes of the SPARC Phase 2 Trial;International Journal of Radiation Oncology*Biology*Physics;2024-09

2. Long-term evaluation of the safety of a rectal-prostate spacer, the ProSpace® balloon, in patients treated with radiotherapy for prostate cancer;BMC Cancer;2024-08-01

3. A Phase 1 Trial of Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer After Brachytherapy;International Journal of Radiation Oncology*Biology*Physics;2024-08

4. Oncological and Functional Outcomes of Whole-Gland HIFU as the Primary Treatment for Localized Prostate Cancer: A Systematic Review;Clinical Genitourinary Cancer;2024-08

5. Tolérance à court et moyen terme d’une radiothérapie prostatique hypofractionnée selon la technique du boost intégré;Cancer/Radiothérapie;2024-08